Inflammatory Bowel Disease (IBD) is a term mainly used to describe two long-term conditions: ulcerative colitis (UC) and Crohn's disease (CD).
The incidence and prevalence of IBD are increasing over time and in virtually every region of the world.1,2
CD and UC complication rates are high2
Read about the landmark Study 3.4 in patients with Crohn’s disease and ulcerative colitis
Infliximab mechanism of action
Support & Resources
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020